Emily Fennell, PhD student in Lee Graves’ lab, won an Impact Award for her project “Multi-omic Analysis of Pharmacological ClpP Activation in Triple-Negative Breast Cancer Cells.” Fennell’s research focuses on breast cancer—which is the leading cause of new cancer diagnoses in women. Triple-negative breast cancer is considered the most aggressive breast cancer subtype and is in need of more effective treatments. A drug, ONC201, has been identified in a chemical screen as a promising new anticancer therapeutic. Fennell’s research could be used to develop co-treatment regimens to enhance overall therapeutic effects. The Graduate School’s Impact Awards are designed to recognize the significance of graduate student research and their contributions to North Carolina in areas of education, economic, physical, social or cultural well-being. All of the eleven awardees, whose research interests range from tidal creek accretion to pediatric obesity, are emblematic of graduate students and their dedication to improving the lives of North Carolinians. Update: Emily was recognized in the Carolina Graduate School magazine for her work under the direction of Professor Lee Graves.